EUVIMEDEUVIMED entdecken
BeobachtungsstudieKohortenstudieOpen Access · CC BY 4.0

Hospital‐Admitted Injection‐Related Infections Among Incarcerated People Who Inject Drugs in Australia: A Retrospective Cohort Study

Andrew Palmer iD, Matthew Carter, Jeremy Yeo, Cecilia Shim, Jason Connor, Jeremy Hayllar, Gerald Holtmann iD, Naomi Moy iD, Elliott G Playford, Naomi Runnegar, Paul J Clark iD

Medical Journal of Australia · 2026-06 · 224 (6)

DOI: 10.5694/mja2.70224 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Medical Journal of Australia, online erschienen am 14.06.2026. Verfasst von Andrew Palmer und 10 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology and Hepatology, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia. Hauptthemen laut MEDLINE: Hospitalization, Prisoners, Substance Abuse, Intravenous. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To characterise the clinical, microbiological and economic burden of hospital‐admitted, injection‐related infections among incarcerated people who inject drugs. Study Type Retrospective observational cohort study.

Setting

Secure unit of the Princess Alexandra Hospital, Brisbane, Australia.

Participants

Adults incarcerated in Queensland prisons who were admitted to hospital with an injection‐related infection between 1 July 2019 and 30 June 2023. Main Outcome Measures Types of injection‐related infection, microbiological findings, requirement for surgical or radiological source control, hospital length of stay and inpatient healthcare costs.

Results

There were 321 hospital admissions for injection‐related infection among 265 patients, accounting for 282 unique infections. Most patients were male (241; 90.9%), with a mean age of 33 years (standard deviation [SD], 7.4 years), and 76 (28.7%) identified as First Nations. The most frequent infections were soft tissue infections (77/282; 27.3%), acute hepatitis C (64/282; 22.7%) and cellulitis (43/282; 15.2%). Surgical or radiological source control was required in 95 infections (34.0%), and infectious diseases consultation occurred in 130 infections (46.1%). Among 39 true‐positive blood cultures, Staphylococcus aureus was identified in 17 (43.6%), Burkholderia species in 10 (25.6%) and non‐tuberculous Mycobacterium species in 3 (7.7%). Among the 218 non‐acute hepatitis C infections, 50 (22.9%) were hepatitis C virus (HCV) RNA positive. Overall, HCV RNA was present in 114 of 282 infections (40.4%). The total inflation‐adjusted inpatient cost was $8.39 million, with a median cost per infection of $11,602 (interquartile range, $7426–$34,544).

Conclusion

Injection‐related infections among incarcerated people who inject drugs were associated with substantial morbidity and healthcare costs in this large hospital cohort. A wide clinical spectrum was observed, including atypical pathogens, and clinically overt acute hepatitis C requiring hospital admission. These findings describe a significant burden of preventable disease in custodial settings and support the introduction of established primary prevention and harm‐reduction interventions in prisons.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HospitalizationPrisonersSubstance Abuse, IntravenousAdultFemaleHumansMaleAustraliaHepatitis CLength of StayQueenslandRetrospective StudiesSoft Tissue InfectionsCohort Studies

Stichwörter der Autor:innen

bacterial infectionscost of illnesshepatitis Cmycobacteriumprevention and controlprisonpublic healthpublic policysocial justicesubstance abuse

Autor:innen und Institutionen

  • Gastroenterology and Hepatology, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.
  • Alcohol and Drug Assessment Unit, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.
  • The University of Queensland, Herston, Queensland, Australia.
  • National Centre for Youth Substance Use Research, The University of Queensland, Brisbane, Queensland, Australia.
  • Metro North Mental Health, Alcohol and Drug Service, Brisbane, Queensland, Australia.
  • Infection Management Services, Princess Alexandra Hospital, Brisbane, Queensland, Australia.

ORCID-Profile: Andrew Palmer, Gerald Holtmann, Naomi Moy, Paul J Clark

Zitieren

APA

Palmer, A., Carter, M., Yeo, J., Shim, C., Connor, J., Hayllar, J., Holtmann, G., Moy, N., Playford, E. G., Runnegar, N., & Clark, P. J. (2026). Hospital‐Admitted Injection‐Related Infections Among Incarcerated People Who Inject Drugs in Australia: A Retrospective Cohort Study. Medical Journal of Australia, 224(6). https://doi.org/10.5694/mja2.70224

Vancouver

Palmer A, Carter M, Yeo J, Shim C, Connor J, Hayllar J, et al. Hospital‐Admitted Injection‐Related Infections Among Incarcerated People Who Inject Drugs in Australia: A Retrospective Cohort Study. Medical Journal of Australia. 2026;224(6). doi:10.5694/mja2.70224

BibTeX
@article{Palmer2026,
  author = {Palmer, Andrew and Carter, Matthew and Yeo, Jeremy and Shim, Cecilia and Connor, Jason and Hayllar, Jeremy and Holtmann, Gerald and Moy, Naomi and Playford, Elliott G and Runnegar, Naomi and Clark, Paul J},
  title = {Hospital‐Admitted Injection‐Related Infections Among Incarcerated People Who Inject Drugs in Australia: A Retrospective Cohort Study},
  journal = {Medical Journal of Australia},
  year = {2026},
  volume = {224},
  number = {6},
  doi = {10.5694/mja2.70224}
}
Kostenlos starten →